Treatment of acute myeloid leukemia in children: A practical perspective
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of acute myeloid leukemia in children: A practical perspective
Authors
Keywords
-
Journal
PEDIATRIC BLOOD & CANCER
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-04-12
DOI
10.1002/pbc.28979
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Structural Variants Involving MLLT10/AF10 Are Associated with Adverse Outcome in AML Regardless of the Partner Gene - a COG/Tpaml Study
- (2020) Rhonda E. Ries et al. BLOOD
- Sorafenib in Combination with Standard Chemotherapy for Children with High Allelic Ratio FLT3/ITD+ AML Improves Event-Free Survival and Reduces Relapse Risk: A Report from the Children's Oncology Group Protocol AAML1031
- (2020) Jessica A. Pollard et al. BLOOD
- Impact of a Risk-Adapted Treatment Approach in Pediatric AML: A Report of the AML-BFM Registry 2012
- (2020) Mareike Rasche et al. BLOOD
- Bortezomib with standard chemotherapy for children with acute myeloid leukemia does not improve treatment outcomes: a report from the Children’s Oncology Group
- (2020) Richard Aplenc et al. HAEMATOLOGICA
- Nucleophosmin mutations confer an independent favorable prognostic impact in 869 pediatric patients with acute myeloid leukemia
- (2020) Lu-Hong Xu et al. Blood Cancer Journal
- Advances in the Treatment of Acute Myeloid Leukemia: New Drugs and New Challenges
- (2020) Nicholas J. Short et al. Cancer Discovery
- Venetoclax in combination with cytarabine with or without idarubicin in children with relapsed or refractory acute myeloid leukaemia: a phase 1, dose-escalation study
- (2020) Seth E Karol et al. LANCET ONCOLOGY
- Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents
- (2020) Andrew D.J. Pearson et al. EUROPEAN JOURNAL OF CANCER
- Morphologic remission status is limited compared to ΔN flow cytometry: a Children’s Oncology Group AAML0531 report
- (2020) Lisa Eidenschink Brodersen et al. Blood Advances
- Targeting FLT3 mutations in AML: review of current knowledge and evidence
- (2019) Naval Daver et al. LEUKEMIA
- Derivation of Anthracycline and Anthraquinone Equivalence Ratios to Doxorubicin for Late-Onset Cardiotoxicity
- (2019) Elizabeth A. M. Feijen et al. JAMA Oncology
- Hematopoietic stem-cell transplantation in children with refractory acute myeloid leukemia
- (2019) Yasuhiro Okamoto et al. BONE MARROW TRANSPLANTATION
- Unrelated donor hematopoietic stem cell transplantation for pediatric de novo acute myeloid leukemia with intermediate‐ or high‐risk cytogenetics
- (2019) Eu Gene Park et al. PEDIATRIC TRANSPLANTATION
- Functional Properties of KIT Mutations Are Associated with Differential Clinical Outcomes and Response to Targeted Therapeutics in CBF Acute Myeloid Leukemia
- (2019) Katherine Tarlock et al. CLINICAL CANCER RESEARCH
- Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials
- (2019) Grace Egan et al. Cancer Medicine
- Transcriptome Profiling of Glycosylation Genes Defines Correlation with E-Selectin Ligand Expression and Clinical Outcome in AML
- (2019) Amanda R. Leonti et al. BLOOD
- In Vivo Evaluation of Mesothelin As a Therapeutic Target in Pediatric Acute Myeloid Leukemia
- (2019) Anilkumar Gopalakrishnapillai et al. BLOOD
- Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation
- (2019) Thomas Lehrnbecher et al. CLINICAL INFECTIOUS DISEASES
- Effect of Caspofungin vs Fluconazole Prophylaxis on Invasive Fungal Disease Among Children and Young Adults With Acute Myeloid Leukemia
- (2019) Brian T. Fisher et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML
- (2019) Alexander E. Perl et al. NEW ENGLAND JOURNAL OF MEDICINE
- How close are we to CAR T-cell therapy for AML?
- (2019) Saar I. Gill BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
- (2018) Gerrit J. Schuurhuis et al. BLOOD
- Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia
- (2018) Ashley A. Newcombe et al. EXPERIMENTAL HEMATOLOGY
- Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012
- (2018) Mareike Rasche et al. LEUKEMIA
- Acute myelogenous leukemia in adolescents and young adults
- (2018) Ursula Creutzig et al. PEDIATRIC BLOOD & CANCER
- Prognostic impact of t(16;21)(p11;q22) and t(16;21)(q24;q22) in pediatric AML: a retrospective study by the I-BFM Study Group
- (2018) Sanne Noort et al. BLOOD
- Effect of Levofloxacin Prophylaxis on Bacteremia in Children With Acute Leukemia or Undergoing Hematopoietic Stem Cell Transplantation
- (2018) Sarah Alexander et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
- (2018) Courtney D. DiNardo et al. BLOOD
- CBFA2T3-GLIS2-positive acute myeloid leukaemia. A peculiar paediatric entity
- (2018) Riccardo Masetti et al. BRITISH JOURNAL OF HAEMATOLOGY
- Occurrence of Treatment-Related Cardiotoxicity and Its Impact on Outcomes Among Children Treated in the AAML0531 Clinical Trial: A Report From the Children’s Oncology Group
- (2018) Kelly D. Getz et al. JOURNAL OF CLINICAL ONCOLOGY
- Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias
- (2018) Shahzya Chaudhury et al. Nature Communications
- Characterization of SGN-CD123A, A Potent CD123-Directed Antibody–Drug Conjugate for Acute Myeloid Leukemia
- (2017) Fu Li et al. MOLECULAR CANCER THERAPEUTICS
- Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia
- (2017) Silvia Arcangeli et al. MOLECULAR THERAPY
- The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions
- (2017) Hamid Bolouri et al. NATURE MEDICINE
- Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
- (2017) Richard M. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- FISH identifies a KAT6A/CREBBP fusion caused by a cryptic insertional t(8;16) in a case of spontaneously remitting congenital acute myeloid leukemia with a normal karyotype
- (2017) Rachel Barrett et al. PEDIATRIC BLOOD & CANCER
- A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML
- (2017) Lia Gore et al. Clinical Epigenetics
- Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO-AML 2004 study
- (2016) Anne Tierens et al. BRITISH JOURNAL OF HAEMATOLOGY
- A Phase I Study of Quizartinib Combined with Chemotherapy in Relapsed Childhood Leukemia: A Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Study
- (2016) Todd M. Cooper et al. CLINICAL CANCER RESEARCH
- CD33 Expression and Its Association With Gemtuzumab Ozogamicin Response: Results From the Randomized Phase III Children’s Oncology Group Trial AAML0531
- (2016) Jessica A. Pollard et al. JOURNAL OF CLINICAL ONCOLOGY
- Characterization of children with FLT3-ITD acute myeloid leukemia: a report from the AIEOP AML-2002 study group
- (2016) E Manara et al. LEUKEMIA
- A recurrent immunophenotype at diagnosis independently identifies high-risk pediatric acute myeloid leukemia: a report from Children’s Oncology Group
- (2016) L Eidenschink Brodersen et al. LEUKEMIA
- NUP98 is rearranged in 3.8% of pediatric AML forming a clinical and molecular homogenous group with a poor prognosis
- (2016) S Struski et al. LEUKEMIA
- A 17-gene stemness score for rapid determination of risk in acute leukaemia
- (2016) Stanley W. K. Ng et al. NATURE
- Acute myeloid leukemia in children: Current status and future directions
- (2016) Takashi Taga et al. PEDIATRICS INTERNATIONAL
- Comparison of Outcomes for Pediatric Patients With Acute Myeloid Leukemia in Remission and Undergoing Allogeneic Hematopoietic Cell Transplantation With Myeloablative Conditioning Regimens Based on Either Intravenous Busulfan or Total Body Irradiation: A Report From the Japanese Society for Hematopoietic Cell Transplantation
- (2015) Hiroyuki Ishida et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Targeting CD123 in acute myeloid leukemia using a T-cell-directed dual-affinity retargeting platform
- (2015) M. Al-Hussaini et al. BLOOD
- Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program
- (2015) V. Barlogis et al. HAEMATOLOGICA
- Clinical Impact of Additional Cytogenetic Aberrations,cKITandRASMutations, and Treatment Elements in Pediatric t(8;21)-AML: Results From an International Retrospective Study by the International Berlin-Frankfurt-Münster Study Group
- (2015) Kim Klein et al. JOURNAL OF CLINICAL ONCOLOGY
- Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia
- (2015) C. Michel Zwaan et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
- (2015) Christoph Röllig et al. LANCET ONCOLOGY
- Late cardiomyopathy in childhood acute myeloid leukemia survivors: a study from the L.E.A. program
- (2015) V. Barlogis et al. HAEMATOLOGICA
- Outcomes after use of two standard ablative regimens in patients with refractory acute myeloid leukaemia: a retrospective, multicentre, registry analysis
- (2015) Arnon Nagler et al. Lancet Haematology
- High Doses of Daunorubicin during Induction Therapy of Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Prospective Clinical Trials
- (2015) Qiang Gong et al. PLoS One
- NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report
- (2014) F. Ostronoff et al. BLOOD
- Transplantation for children with acute myeloid leukemia: a comparison of outcomes with reduced intensity and myeloablative regimens
- (2014) M. Bitan et al. BLOOD
- Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML
- (2014) J. E. Lancet et al. BLOOD
- Pre-transplant MRD predicts outcome following reduced-intensity and myeloablative allogeneic hemopoietic SCT in AML
- (2014) C Anthias et al. BONE MARROW TRANSPLANTATION
- Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation
- (2014) Mariana Bastos-Oreiro et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients
- (2014) J. D. Sandahl et al. HAEMATOLOGICA
- Gemtuzumab Ozogamicin in Children and Adolescents With De Novo Acute Myeloid Leukemia Improves Event-Free Survival by Reducing Relapse Risk: Results From the Randomized Phase III Children's Oncology Group Trial AAML0531
- (2014) Alan S. Gamis et al. JOURNAL OF CLINICAL ONCOLOGY
- Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
- (2014) Juan Carlos Plana et al. JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY
- Dexrazoxane exposure and risk of secondary acute myeloid leukemia in pediatric oncology patients
- (2014) Alix E. Seif et al. PEDIATRIC BLOOD & CANCER
- Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
- (2014) H Matsuo et al. Blood Cancer Journal
- Intermediate-risk acute myeloid leukemia therapy: current and future
- (2014) K. Dohner et al. Hematology-American Society of Hematology Education Program
- Pediatric acute myeloid leukemia with t(8;16)(p11;p13), a distinct clinical and biological entity: a collaborative study by the International-Berlin-Frankfurt-Munster AML-study group
- (2013) E. A. Coenen et al. BLOOD
- CBFA2T3-GLIS2 fusion transcript is a novel common feature in pediatric, cytogenetically normal AML, not restricted to FAB M7 subtype
- (2013) R. Masetti et al. BLOOD
- Results of the AIEOP AML 2002/01 multicenter prospective trial for the treatment of children with acute myeloid leukemia
- (2013) A. Pession et al. BLOOD
- Randomized trial comparing liposomal daunorubicin with idarubicin as induction for pediatric acute myeloid leukemia: results from Study AML-BFM 2004
- (2013) U. Creutzig et al. BLOOD
- NUP98-NSD1gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia
- (2013) Norio Shiba et al. GENES CHROMOSOMES & CANCER
- NUP98-NSD1fusion in association withFLT3-ITD mutation identifies a prognostically relevant subgroup of pediatric acute myeloid leukemia patients suitable for monitoring by real time quantitative PCR
- (2013) Susanna Akiki et al. GENES CHROMOSOMES & CANCER
- Acute myeloid leukemia with translocation t(3;5): new molecular insights
- (2013) F. Dumezy et al. HAEMATOLOGICA
- Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
- (2013) Daisuke Tomizawa et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Sorafenib in Combination With Intensive Chemotherapy in Elderly Patients With Acute Myeloid Leukemia: Results From a Randomized, Placebo-Controlled Trial
- (2013) Hubert Serve et al. JOURNAL OF CLINICAL ONCOLOGY
- Optimization of Chemotherapy for Younger Patients With Acute Myeloid Leukemia: Results of the Medical Research Council AML15 Trial
- (2013) Alan K. Burnett et al. JOURNAL OF CLINICAL ONCOLOGY
- Excess treatment reduction including anthracyclines results in higher incidence of relapse in core binding factor acute myeloid leukemia in children
- (2013) D Tomizawa et al. LEUKEMIA
- The prognostic effect of high diagnosticWT1gene expression in pediatric AML depends onWT1SNP rs16754 status: Report from the Children's Oncology Group
- (2013) Phoenix A. Ho et al. PEDIATRIC BLOOD & CANCER
- Outcome of pediatric patients with acute myeloid leukemia (AML) and −5/5q− abnormalities from five pediatric AML treatment protocols: A report from the Children's Oncology Group
- (2013) Donna L. Johnston et al. PEDIATRIC BLOOD & CANCER
- Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group
- (2012) M. R. Loken et al. BLOOD
- Gemtuzumab ozogamicin as postconsolidation therapy does not prevent relapse in children with AML: results from NOPHO-AML 2004
- (2012) H. Hasle et al. BLOOD
- How I treat pediatric acute myeloid leukemia
- (2012) J. E. Rubnitz BLOOD
- An Inv(16)(p13.3q24.3)-Encoded CBFA2T3-GLIS2 Fusion Protein Defines an Aggressive Subtype of Pediatric Acute Megakaryoblastic Leukemia
- (2012) Tanja A. Gruber et al. CANCER CELL
- The Origin and Evolution of Mutations in Acute Myeloid Leukemia
- (2012) John S. Welch et al. CELL
- Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia
- (2012) Hiroto Inaba et al. JOURNAL OF CLINICAL ONCOLOGY
- Improved Survival for Children and Adolescents With Acute Lymphoblastic Leukemia Between 1990 and 2005: A Report From the Children's Oncology Group
- (2012) Stephen P. Hunger et al. JOURNAL OF CLINICAL ONCOLOGY
- Leveraging Administrative Data to Monitor Rituximab Use in 2875 Patients at 42 Freestanding Children's Hospitals across the United States
- (2012) Marko Kavcic et al. JOURNAL OF PEDIATRICS
- The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach
- (2012) Jan J. Cornelissen et al. Nature Reviews Clinical Oncology
- Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia
- (2011) A. Staffas et al. BLOOD
- NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern
- (2011) I. H. I. M. Hollink et al. BLOOD
- Results of a randomized trial in children with Acute Myeloid Leukaemia: Medical Research Council AML12 trial
- (2011) Brenda E. S. Gibson et al. BRITISH JOURNAL OF HAEMATOLOGY
- AAML03P1, a pilot study of the safety of gemtuzumab ozogamicin in combination with chemotherapy for newly diagnosed childhood acute myeloid leukemia
- (2011) Todd M. Cooper et al. CANCER
- CNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML-BFM98 and 2004
- (2011) Ursula Creutzig et al. PEDIATRIC BLOOD & CANCER
- Long-term health impacts of hematopoietic stem cell transplantation inform recommendations for follow-up
- (2011) Smita Bhatia Expert Review of Hematology
- Management of Refractory Acute Myeloid Leukemia: Re-induction Therapy or Straight to Transplantation?
- (2011) E. J. Feldman et al. Current Hematologic Malignancy Reports
- Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML
- (2010) J. A. Pollard et al. BLOOD
- Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials
- (2010) D. Grimwade et al. BLOOD
- HighEVI1Expression Predicts Outcome in Younger Adult Patients With Acute Myeloid Leukemia and Is Associated With Distinct Cytogenetic Abnormalities
- (2010) Stefan Gröschel et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98
- (2010) Christine von Neuhoff et al. JOURNAL OF CLINICAL ONCOLOGY
- Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12
- (2010) Christine J. Harrison et al. JOURNAL OF CLINICAL ONCOLOGY
- Response-Guided Induction Therapy in Pediatric Acute Myeloid Leukemia With Excellent Remission Rate
- (2010) Jonas Abrahamsson et al. JOURNAL OF CLINICAL ONCOLOGY
- Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
- (2010) Jeffrey E Rubnitz et al. LANCET ONCOLOGY
- Clinical significance of flowcytometric minimal residual disease detection in pediatric acute myeloid leukemia patients treated according to the DCOG ANLL97/MRC AML12 protocol
- (2010) V H J van der Velden et al. LEUKEMIA
- The presence of central nervous system disease at diagnosis in pediatric acute myeloid leukemia does not affect survival: A Children's Oncology Group study
- (2010) Donna L. Johnston et al. PEDIATRIC BLOOD & CANCER
- Hematopoietic Stem Cell Transplantation for Leukemia
- (2010) Alan S. Wayne et al. PEDIATRIC CLINICS OF NORTH AMERICA
- Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study
- (2009) B. V. Balgobind et al. BLOOD
- High burden of late effects after haematopoietic stem cell transplantation in childhood: a single-centre study
- (2009) D Bresters et al. BONE MARROW TRANSPLANTATION
- Risk-Stratified Therapy and the Intensive Use of Cytarabine Improves the Outcome in Childhood Acute Myeloid Leukemia: The AML99 Trial From the Japanese Childhood AML Cooperative Study Group
- (2009) Ichiro Tsukimoto et al. JOURNAL OF CLINICAL ONCOLOGY
- Impact of Disease Risk on Efficacy of Matched Related Bone Marrow Transplantation for Pediatric Acute Myeloid Leukemia: The Children's Oncology Group
- (2008) John T. Horan et al. JOURNAL OF CLINICAL ONCOLOGY
- Favorable prognostic impact of NPM1 gene mutations in childhood acute myeloid leukemia, with emphasis on cytogenetically normal AML
- (2008) I H I M Hollink et al. LEUKEMIA
- Coding polymorphisms in CD33 and response to gemtuzumab ozogamicin in pediatric patients with AML: a pilot study
- (2008) J K Lamba et al. LEUKEMIA
- Infections in pediatric acute myeloid leukemia: Lessons learned and unresolved questions
- (2008) Lillian Sung et al. PEDIATRIC BLOOD & CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation